Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma

MLA

Jun Li, et al. “Targeting LRRC41 as a Potential Therapeutic Approach for Hepatocellular Carcinoma.” Frontiers in Molecular Biosciences, vol. 10, Dec. 2023. EBSCOhost, https://doi.org/10.3389/fmolb.2023.1300294.

APA

Jun Li, Chenjie Qin, Yicheng Wu, Sheng Cheng, Yuanqing Wang, Huijie Chen, Fangli Chen, Bingdi Chen, & Jutang Li. (2023). Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma. Frontiers in Molecular Biosciences, 10. https://doi.org/10.3389/fmolb.2023.1300294

Chicago

Jun Li, Chenjie Qin, Yicheng Wu, Sheng Cheng, Yuanqing Wang, Huijie Chen, Fangli Chen, Bingdi Chen, and Jutang Li. 2023. “Targeting LRRC41 as a Potential Therapeutic Approach for Hepatocellular Carcinoma.” Frontiers in Molecular Biosciences 10 (December). doi:10.3389/fmolb.2023.1300294.